Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains.

scientific article

Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2990.2011.01206.X
P698PubMed publication ID21718343

P50authorHiroko TabunokiQ56986263
P2093author name stringT Ishida
Y Saito
J Satoh
K Arima
P2860cites workGamma-secretase activating protein is a therapeutic target for Alzheimer's diseaseQ24298408
Close association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brainsQ24317142
Gleevec inhibits β-amyloid production but not Notch cleavageQ24683037
Neuropathological stageing of Alzheimer-related changesQ27860862
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's diseaseQ29614948
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryQ34556945
Inhibition and modulation of gamma-secretase for Alzheimer's diseaseQ37215842
Novel research horizons for presenilins and γ-secretases in cell biology and diseaseQ37770248
Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.Q43143033
Alzheimer's disease: Selectively tuning gamma-secretase.Q55053379
P433issue2
P921main subjectAlzheimer's diseaseQ11081
immunohistochemistryQ899285
P304page(s)132-141
P577publication date2012-04-01
P1433published inNeuropathology and Applied NeurobiologyQ7002494
P1476titleImmunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains
P478volume38